Agata Kabut-Wieczorkiewicz
Dąbrowski Street 25
Katowice, SL 40032, Poland
Katowice, SL 40032, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Pre-transplant JAK-inhibition improves post-transplant outcome in myelofibrosis.
Journal: Clinical and experimental medicine
Published: December 10, 2025
"B" symptoms and CBV conditioning negatively impact survival in mantle cell lymphoma patients undergoing autologous stem cell transplantation.
Journal: Annals of hematology
Published: July 28, 2025
Post-transplant sorafenib effectively prevents relapse in FLT3-mutated acute myeloid leukemia.
Journal: Expert review of hematology
Published: June 27, 2025
Benefits of primary prophylaxis with letermovir in patients after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Journal: Expert review of hematology
Published: May 23, 2025
Second allogeneic transplantation in relapsed acute leukemia - a risk worth taking?
Journal: Annals of hematology
Published: May 08, 2025
Donor's age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience.
Journal: Annals of hematology
Published: April 27, 2024
Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: February 12, 2024
Effect of transplanted cells with CD184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma.
Journal: Experimental hematology
Published: March 07, 2023
Allogeneic hematopoietic stem cell transplantation for acquired severe aplastic anemia: a summary of a 20-year experience.
Journal: Polish archives of internal medicine
Published: March 02, 2023
Ruxolitinib is highly effective in steroid-resistant graft-versus-host disease: real-world data from a single center.
Journal: Polish archives of internal medicine
Published: February 21, 2023
Allogeneic hematopoietic stem cell transplantation remains a feasible approach for elderly with acute myeloid leukemia: a 10-year experience.
Journal: Annals of hematology
Published: December 29, 2022
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Single-Centre Experience.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 16, 2022
Last Updated: 09/26/2026